V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003463 | 280002588 | 1.77 | 85 | Neo-adjuvant (N) | 2015-05-14 | 2015-05-28 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | 280025599 | CISPLATIN + FLUOROURACIL |
| 280003464 | 280002589 | 1.63 | 65 | Neo-adjuvant (N) | 2015-08-15 | 2015-09-18 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025601 | CISPLATIN + FLUOROURACIL |
| 280003465 | 280002590 | null | 67.2 | null | null | 2017-08-23 | CETUXIMAB + RT | null | Y | 280025603 | CETUXIMAB + RT |
| 280003466 | 280002591 | 1.6 | 89 | Adjuvant (A) | 2017-03-21 | 2017-03-21 | Doxorubicin + Ifosfamide | 2 | N | 280025604 | DOXORUBICIN + IFOSFAMIDE |
| 280003467 | 280002592 | 1.77 | 48.6 | Neo-adjuvant (N) | 2015-01-24 | 2015-02-17 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 280025605 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003468 | 280002593 | 1.72 | 70 | Palliative (P) | 2018-02-21 | 2018-02-23 | Doxorubicin + Ifosfamide | N | N | 280025607 | DOXORUBICIN + IFOSFAMIDE |
| 280003469 | 280002594 | 1.86 | 108 | Curative (C) | null | 2014-04-15 | CETUXIMAB + RT | N | Y | 280025608 | CETUXIMAB + RT |
| 280003470 | 280002594 | 1.72 | 100 | Curative (C) | 2014-01-23 | 2014-02-05 | Doxorubicin + Ifosfamide | 2 | N | 280025608 | DOXORUBICIN + IFOSFAMIDE |
| 280003471 | 280002595 | 1.65 | 63.4 | Curative (C) | 2016-04-13 | 2016-04-13 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025611 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003472 | 280002596 | null | null | Palliative (P) | 2015-08-07 | 2015-08-19 | Doxorubicin + Ifosfamide | 02 | N | 280025612 | DOXORUBICIN + IFOSFAMIDE |
| 280003473 | 280002596 | 1.57 | 81.5 | Curative (C) | 2014-03-16 | 2014-04-04 | Cetuximab + Radiotherapy Load | 2 | N | 280025612 | CETUXIMAB + RT |
| 280003474 | 280002597 | 1.76 | 81.2 | Neo-adjuvant (N) | 2014-11-21 | 2014-12-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025615 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003477 | 280009734 | 1.52 | 91.3 | Neo-adjuvant (N) | 2017-09-30 | 2017-10-02 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025618 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003478 | 280009734 | 1.93 | 72 | Neo-adjuvant (N) | null | 2018-02-03 | Doxorubicin + Ifosfamide | N | N | 280025618 | DOXORUBICIN + IFOSFAMIDE |
| 280003479 | 280009734 | 1.7 | null | Neo-adjuvant (N) | 2016-06-30 | 2016-07-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025618 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003480 | 280011815 | 1.72 | 119 | Curative (C) | 2017-03-31 | 2017-04-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025622 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003481 | 280002599 | 1.6 | 100.8 | null | 2014-02-24 | 2014-03-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025623 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003482 | 280002600 | 1.84 | 96.4 | null | 2016-06-10 | 2016-06-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025624 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003483 | 280002601 | 1.54 | null | Curative (C) | null | 2015-08-02 | Cetuximab + Radiotherapy Load | null | Y | 280025625 | CETUXIMAB + RT |
| 280003484 | 280002601 | 1.66 | 82.3 | Neo-adjuvant (N) | 2016-05-27 | 2016-06-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025625 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003485 | 280002602 | 1.54 | 79.4 | Neo-adjuvant (N) | 2017-02-17 | 2017-02-20 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025627 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003486 | 280002603 | 1.8 | 95.9 | Neo-adjuvant (N) | 2013-08-02 | 2013-08-02 | Doxorubicin + Ifosfamide | 02 | null | 280025630 | DOXORUBICIN + IFOSFAMIDE |
| 280003487 | 280002604 | 1.75 | null | Adjuvant (A) | 2014-09-11 | 2014-09-18 | Doxorubicin + Ifosfamide | N | N | 280025632 | DOXORUBICIN + IFOSFAMIDE |
| 280003488 | 280002605 | 1.74 | 57 | Neo-adjuvant (N) | 2013-12-26 | 2014-01-20 | Doxorubicin + Ifosfamide | N | N | 280025635 | DOXORUBICIN + IFOSFAMIDE |
| 280003489 | 280002606 | 1.82 | 92 | Adjuvant (A) | 2017-11-24 | 2017-12-02 | Cetuximab + Radiotherapy Load | 02 | N | 280025636 | CETUXIMAB + RT |
| 280003490 | 280002607 | 1.5 | 67.4 | Curative (C) | null | 2013-02-12 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025638 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003491 | 280002607 | 1.67 | 110 | Curative (C) | 2016-03-29 | 2016-04-06 | CETUXIMAB + RT | N | Y | 280025638 | CETUXIMAB + RT |
| 280003492 | 280002608 | 1.65 | 103 | Adjuvant (A) | 2014-10-15 | 2014-10-26 | CETUXIMAB + RT | N | Y | 280025641 | CETUXIMAB + RT |
| 280003493 | 280002609 | 1.75 | 108.8 | Disease modification (D) | null | 2013-04-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025643 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003494 | 280007314 | null | 83.4 | Curative (C) | null | 2014-03-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025646 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003495 | 280007314 | 1.73 | 64 | Not known (9) | 2013-01-01 | 2013-02-03 | CETUXIMAB + RT | 2 | null | 280025646 | CETUXIMAB + RT |
| 280003496 | 280002610 | 1.65 | null | Curative (C) | 2016-11-27 | 2016-11-27 | CISPLATIN + FLUOROURACIL | 02 | N | 280025648 | CISPLATIN + FLUOROURACIL |
| 280003497 | 280002610 | 1.73 | 60.4 | Curative (C) | null | 2013-04-07 | CETUXIMAB + RT | N | Y | 280025648 | CETUXIMAB + RT |
| 280003498 | 280002611 | 1.7 | 94 | Neo-adjuvant (N) | 2015-03-04 | 2015-03-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025652 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003499 | 280007316 | 1.9 | 57 | Palliative (P) | 2013-02-12 | 2013-02-12 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025653 | CISPLATIN + FLUOROURACIL |
| 280003500 | 280002612 | 1.59 | 92 | Palliative (P) | null | 2017-05-27 | DOXORUBICIN + IFOSFAMIDE | null | null | 280025654 | DOXORUBICIN + IFOSFAMIDE |
| 280003501 | 280002612 | 1.7 | 82.2 | Neo-adjuvant (N) | 2014-09-05 | 2014-09-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025654 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003502 | 280002612 | 1.78 | 58.5 | Curative (C) | 2015-08-22 | 2015-09-27 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 280025654 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003503 | 280002613 | 1.7 | 83.6 | Neo-adjuvant (N) | null | 2013-08-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025660 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003504 | 280002613 | 1.73 | 74.2 | Neo-adjuvant (N) | 2014-02-28 | 2014-05-03 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025660 | CISPLATIN + FLUOROURACIL |
| 280003505 | 280002614 | 1.78 | 69 | Curative (C) | 2017-08-20 | 2017-09-04 | Cetuximab + Radiotherapy Load | N | Y | 280025666 | CETUXIMAB + RT |
| 280003506 | 280002615 | 1.78 | 109.4 | Neo-adjuvant (N) | 2014-09-07 | 2014-09-07 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280025668 | CISPLATIN + FLUOROURACIL |
| 280003507 | 280002616 | 1.63 | 81.9 | null | 2017-03-14 | 2017-03-23 | CISPLATIN + FLUOROURACIL | 02 | null | 280025669 | CISPLATIN + FLUOROURACIL |
| 280003508 | 280002617 | 1.88 | 68.4 | Adjuvant (A) | 2017-07-15 | 2017-07-15 | Doxorubicin + Ifosfamide | 02 | null | 280025670 | DOXORUBICIN + IFOSFAMIDE |
| 280003509 | 280002618 | 1.82 | 68.5 | Neo-adjuvant (N) | 2016-11-17 | 2016-11-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025671 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003510 | 280002618 | 1.58 | 79 | null | 2013-09-19 | 2013-10-10 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025671 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003511 | 280002619 | 0 | 53.7 | Neo-adjuvant (N) | 2017-02-19 | 2017-02-20 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280025673 | CISPLATIN + FLUOROURACIL |
| 280003512 | 280007320 | null | 102 | Neo-adjuvant (N) | 2016-07-08 | 2016-07-09 | Cisplatin + Docetaxel +Fluorouracil | N | null | 280025674 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003513 | 280002620 | 1.98 | 93 | Curative (C) | 2017-10-23 | 2017-10-23 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025675 | CISPLATIN + FLUOROURACIL |
| 280003514 | 280002620 | 1.69 | null | Neo-adjuvant (N) | 2017-12-06 | 2018-01-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025675 | CISPLATIN + DOCETAXEL + FLUOROURACIL |